Argitalpenak (29) Miguel Eduardo Sogbe Diaz argitalpenak

filter_list

2025

  1. Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

    Digestive Diseases and Sciences, Vol. 70, Núm. 4, pp. 1530-1539

  2. Arrhythmic storm in a liver transplant recipient: Could bezlotoxumab be the trigger?

    Medicina Clinica

  3. Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study

    Hepatology

  4. Evolving epidemiology of HCC in Spain

    JHEP Reports, Vol. 7, Núm. 5

  5. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis

    Journal of Hepatology, Vol. 82, Núm. 1, pp. 107-119

  6. Phase angle as a reproducible bedside tool to assess reduced muscle mass in patients with decompensated cirrhosis and ascites: An observational cross-sectional study

    Nutrition in Clinical Practice, Vol. 40, Núm. 5, pp. 1107-1114

  7. Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysis

    Carcinogenesis, Vol. 46, Núm. 1

  8. Psychomotor speed from minimal hepatic encephalopathy testing is associated with physical frailty in patients with advanced chronic liver disease

    American Journal of Gastroenterology

  9. The Association of Free Testosterone Levels With Frailty Metrics in Advanced Chronic Liver Disease

    Journal of Clinical Gastroenterology

  10. Tremelimumab for the treatment of hepatocellular carcinoma

    Expert Opinion on Biological Therapy, Vol. 25, Núm. 9, pp. 925-934

2024

  1. Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma

    Biomolecules, Vol. 14, Núm. 6

  2. Efficacy and safety of long-term use of tedizolid in disseminated nocardiosis after heart transplantation

    Transplant Infectious Disease, Vol. 26, Núm. 1

  3. Hypovitaminosis C in the context of the COVID-19 pandemic

    Medicina Clinica, Vol. 162, Núm. 1, pp. 39-40

  4. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

    Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190

2023

  1. Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440

  2. Hepatic eosinophilic infiltration: Cancer or parasite?

    Gastroenterologia y Hepatologia

  3. Partial Radiation Nephrectomy Using 90Y Resin Microspheres: A Treatment Option for Renal Tumors With Malignant Characteristics in Patients Not Candidates for Surgery

    Clinical Nuclear Medicine, Vol. 48, Núm. 11, pp. 960-962

  4. Pneumatocele formation following COVID-19 pneumonia

    Medicina Clinica Practica, Vol. 6, Núm. 1

  5. Prototheca wickerhamii isolation in a patient with bronchiectasis

    Medicina Clinica

  6. Role of preoperative albendazole in the treatment of primary muscular hydatidosis

    Medicina Clinica, Vol. 160, Núm. 12, pp. 564-565